title: Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis.
abstract: Increased intracranial pressure (ICP) plays an important role in the morbidity and mortality of cryptococcal meningoencephalitis. The microbial and host factors that contribute to the development of increased ICP are poorly understood. We found that phenotypic switch variants of Cryptococcus neoformans (smooth and mucoid) differed in their abilities to promote increased ICP in a rat model of cryptococcal meningitis. Rats infected with the mucoid variant developed increased ICP, whereas rats infected with the smooth parent did not. This trend correlated with a shorter survival time and a higher cerebrospinal fluid (CSF) fungal burden for mucoid variant-infected rats, although brain fungal burdens were comparable between mucoid variant- and smooth parent-infected rats. Magnetic resonance imaging revealed enhanced T2 signal intensity over the surfaces of the brains of mucoid variant-infected rats. In addition, more polysaccharide accumulated in the CSF and brains of mucoid variant-infected rats. The accumulation of glucorunoxylomannan was associated with elevated levels of MCP-1 (CCL2) and, accordingly, a more pronounced but ineffective monocytic inflammatory response in the meninges of mucoid variant-infected rats. In summary, these findings suggest that strain-specific characteristics can influence the development of increased ICP and indicate a manner in which phenotypic switching could influence the outcome of a central nervous system infection.
authors.affiliation: Department of Medicine, Golding 702, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461, USA. fries@aecom.yu.edu
authors.forename: B C
authors.initials: BC
authors.lastname: Fries
authors.forename: S C
authors.initials: SC
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Kennan
authors.forename: W
authors.initials: W
authors.lastname: Zhao
authors.forename: A
authors.initials: A
authors.lastname: Casadevall
authors.forename: D L
authors.initials: DL
authors.lastname: Goldman
mesh_terms: D000818:Animals; D001921:Brain / Q000276:immunology / Q000382:microbiology; D002555:Cerebrospinal Fluid / Q000382:microbiology; D015169:Colony Count, Microbial; D003455:Cryptococcus neoformans / Q000145:classification / Q000235:genetics / Q000254:growth & development / Q000472:pathogenicity*; D007427:Intracranial Pressure; D008279:Magnetic Resonance Imaging; D008297:Male; D016919:Meningitis, Cryptococcal / Q000382:microbiology* / Q000503:physiopathology; D008590:Meningoencephalitis / Q000382:microbiology* / Q000503:physiopathology; D010641:Phenotype; D011134:Polysaccharides / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D011134:Polysaccharides
references.citation: Infect Immun. 1999 Nov;67(11):6076-83
references.pmid: 10531269
references.citation: Am J Pathol. 1996 Apr;148(4):1267-74
references.pmid: 8644867
references.citation: Infect Immun. 2000 Jun;68(6):3642-50
references.pmid: 10816523
references.citation: J Neuroimmunol. 2000 Nov 1;111(1-2):10-4
references.pmid: 11063816
references.citation: Med Mycol. 2000 Dec;38(6):407-17
references.pmid: 11204878
references.citation: Clin Infect Dis. 2001 Sep 1;33(5):690-9
references.pmid: 11477526
references.citation: J Clin Invest. 2001 Dec;108(11):1639-48
references.pmid: 11733559
references.citation: J Infect Dis. 2002 Aug 15;186(4):522-30
references.pmid: 12195380
references.citation: Microbes Infect. 2002 Nov;4(13):1345-52
references.pmid: 12443899
references.citation: Infect Dis Clin North Am. 2002 Dec;16(4):837-74, v-vi
references.pmid: 12512184
references.citation: Cell Microbiol. 2003 Aug;5(8):513-22
references.pmid: 12864811
references.citation: Infect Immun. 2003 Nov;71(11):6155-64
references.pmid: 14573631
references.citation: Nat Rev Microbiol. 2003 Oct;1(1):17-24
references.pmid: 15040176
references.citation: Neurology. 1970 Jul;20(7):665-80
references.pmid: 4912250
references.citation: J Clin Invest. 1980 Aug;66(2):243-53
references.pmid: 6995482
references.citation: Am J Pathol. 1980 Oct;101(1):177-94
references.pmid: 7004196
references.citation: Hum Pathol. 1985 Feb;16(2):121-8
references.pmid: 3972394
references.citation: N Engl J Med. 1987 Aug 6;317(6):334-41
references.pmid: 3299095
references.citation: Infect Immun. 1991 Jan;59(1):59-64
references.pmid: 1987064
references.citation: Am J Med. 1991 Sep;91(3):267-72
references.pmid: 1892147
references.citation: Clin Infect Dis. 1992 Mar;14 Suppl 1:S54-9
references.pmid: 1562696
references.citation: J Infect. 1992 Mar;24(2):185-9
references.pmid: 1569310
references.citation: Infect Immun. 1994 Nov;62(11):4755-61
references.pmid: 7927751
references.citation: Infect Immun. 1995 May;63(5):1899-905
references.pmid: 7729900
references.citation: J Clin Microbiol. 1995 Mar;33(3):765-8
references.pmid: 7751394
references.citation: Infect Immun. 1995 Sep;63(9):3448-53
references.pmid: 7642276
references.citation: Antimicrob Agents Chemother. 1995 Sep;39(9):1934-7
references.pmid: 8540694
references.citation: Clin Microbiol Rev. 1995 Oct;8(4):515-48
references.pmid: 8665468
references.citation: J Infect Dis. 1996 Oct;174(4):812-20
references.pmid: 8843221
references.citation: Lab Invest. 1996 Dec;75(6):759-70
references.pmid: 8973471
references.citation: J Infect Dis. 1998 Jan;177(1):260-3
references.pmid: 9419203
references.citation: Infect Immun. 1998 Jan;66(1):89-97
references.pmid: 9423844
references.citation: Clin Diagn Lab Immunol. 1998 May;5(3):410-1
references.pmid: 9606001
references.citation: Clin Infect Dis. 1996 May;22 Suppl 2:S154-60
references.pmid: 8722844
references.citation: Biochem Biophys Res Commun. 1996 Jul 25;224(3):855-62
references.pmid: 8713135
references.citation: Hum Pathol. 1996 Aug;27(8):839-47
references.pmid: 8760020
references.citation: Clin Infect Dis. 1996 Jul;23(1):82-90
references.pmid: 8816134
references.citation: J Infect Dis. 1998 Dec;178(6):1761-6
references.pmid: 9815230
references.citation: Clin Infect Dis. 1998 Nov;27(5):1231-7
references.pmid: 9827275
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14967-72
references.pmid: 9843999
references.citation: Antimicrob Agents Chemother. 1999 Feb;43(2):413-4
references.pmid: 9925548
references.citation: Clin Diagn Lab Immunol. 1999 Mar;6(2):266-8
references.pmid: 10066665
references.citation: Infect Immun. 1999 Jul;67(7):3601-9
references.pmid: 10377145
references.citation: Am J Pathol. 1964 Aug;45:195-207
references.pmid: 14202520
references.citation: J Immunol. 1965 Jun;94:916-20
references.pmid: 14321434
references.citation: Clin Infect Dis. 2000 Jan;30(1):47-54
references.pmid: 10619732